{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:32Z","timestamp":1761959312974,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.rmcr.2022.101599","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T10:17:27Z","timestamp":1643797047000},"page":"101599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Paradoxical worsening of nontuberculous mycobacterial disease after the discontinuation of antitumor necrosis factor therapy: A case report"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-7310","authenticated-orcid":false,"given":"Daijiro","family":"Nabeya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-5409","authenticated-orcid":false,"given":"Tomoo","family":"Kishaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.rmcr.2022.101599_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"43","key":"10.1016\/j.rmcr.2022.101599_bib2","article-title":"Use of steroids to treat anti-tumor necrosis factor \u03b1 induced tuberculosis-associated immune reconstitution inflammatory syndrome: case report and literature review","volume":"99","author":"Nabeya","year":"2020","journal-title":"Med. (Baltim.)"},{"issue":"1","key":"10.1016\/j.rmcr.2022.101599_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/annrheumdis-2011-200690","article-title":"Mycobacterial diseases and antitumour necrosis factor therapy in USA","volume":"72","author":"Winthrop","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.rmcr.2022.101599_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin. Chest Med."},{"issue":"2","key":"10.1016\/j.rmcr.2022.101599_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-200868020-00004","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management","volume":"68","author":"Dhasmana","year":"2008","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.rmcr.2022.101599_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14074","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients","volume":"45","author":"Sueki","year":"2018","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.rmcr.2022.101599_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/s10165-011-0577-6","article-title":"N-B, radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan","volume":"22","author":"Mori","year":"2012","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.rmcr.2022.101599_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jinf.2007.08.007","article-title":"Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients","volume":"55","author":"Salvana","year":"2007","journal-title":"J. Infect."},{"issue":"10","key":"10.1016\/j.rmcr.2022.101599_bib9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/rheumatology\/keq146","article-title":"Possible role of anti-TNF monoclonal antibodies in the treatment of Mycobacterium marinum infection","volume":"49","author":"Garzoni","year":"2010","journal-title":"Rheumatology. (Oxford)"},{"key":"10.1016\/j.rmcr.2022.101599_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2334-14-114","article-title":"Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-\u03b1 inhibitor: a case report","volume":"14","author":"Takazono","year":"2014","journal-title":"BMC Infect. Dis."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:04:44Z","timestamp":1761959084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007122000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":10,"alternative-id":["S2213007122000211"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101599","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical worsening of nontuberculous mycobacterial disease after the discontinuation of antitumor necrosis factor therapy: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101599"}}